Janssen enters into licence with Protagonist

31-05-2017

Janssen enters into licence with Protagonist

Choreograph / iStockphoto.com

Janssen Biotech has entered into a worldwide exclusive licence and collaboration agreement with US-based Protagonist Therapeutics.


Janssen, Johnson & Johnson, Protagonist, patent, licensing agreement, Crohn’s disease

LSIPR